Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

McMaster University

$220,250.00

Microfluidic high-throughput screening device for C. elegans movement based assays

EF 2010-11

Résumé
C. elegans is one of the most widely studied organisms that is of great importance in the study of molecular mechanisms underlying numerous biological and disease processes. Because C. elegans carries more than half of human disease genes and utilizes many of the same mechanisms, the findings in this model can be successfully translated to humans. Furthermore, due to its small size (~1 mm, ~1,000 somatic cells), short generation time (~2.5 days), and transparent body, C. elegans (worms) serves as an ideal laboratory model for understanding the role of human genes in diseases as well as an effective screen to determine the effect of drug candidates in mitigating these diseases. However, current methods of screening worms involve observation of their movement and imaging them following exposure to chemicals. These methods are qualitative, labor-intensive prone to human errors, time consuming, costly and not amenable to high throughput. Automation, standardization and parallelization of screening processes for model organisms is crucial in lowering their cost and enabling their widespread use in drug discovery. We propose to take a novel approach to develop microfluidic devices to study the response of worms to various chemicals. This is based on our recent promising discovery that C. elegans respond to electrical signals and move in a directed manner inside microfluidic channels. This discovery has allowed us, for the first time, to induce movement behaviour on demand and quantitatively measure its response. Here we propose to combine electric stimuli based movement response of the worms with microfabrication and microfluidic technology to develop devices that will screen for drug candidates for Parkinson's disease in a high throughput manner. The successful outcome of this project will be a low cost device that can be used by biologist and pharmaceutical researchers for drug candidate screening using animal models for Parkinson's disease. The technology developed can also be applied with suitable modifications for any movement based disorders, neurological diseases and even obesity and hypertension if expressed in C.elegans.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
222881
Name
Selvaganapathy Ponnambalam R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Microfluidic high-throughput screening device for C. elegans movement based assays
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$220,250
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Electrotaxis
Abstract
C. elegans is one of the most widely studied organisms that is of great importance in the study of molecular mechanisms underlying numerous biological and disease processes. Because C. elegans carries more than half of human disease genes and utilizes many of the same mechanisms, the findings in this model can be successfully translated to humans. Furthermore, due to its small size (~1 mm, ~1,000 somatic cells), short generation time (~2.5 days), and transparent body, C. elegans (worms) serves as an ideal laboratory model for understanding the role of human genes in diseases as well as an effective screen to determine the effect of drug candidates in mitigating these diseases. However, current methods of screening worms involve observation of their movement and imaging them following exposure to chemicals. These methods are qualitative, labor-intensive prone to human errors, time consuming, costly and not amenable to high throughput. Automation, standardization and parallelization of screening processes for model organisms is crucial in lowering their cost and enabling their widespread use in drug discovery. We propose to take a novel approach to develop microfluidic devices to study the response of worms to various chemicals. This is based on our recent promising discovery that C. elegans respond to electrical signals and move in a directed manner inside microfluidic channels. This discovery has allowed us, for the first time, to induce movement behaviour on demand and quantitatively measure its response. Here we propose to combine electric stimuli based movement response of the worms with microfabrication and microfluidic technology to develop devices that will screen for drug candidates for Parkinson's disease in a high throughput manner. The successful outcome of this project will be a low cost device that can be used by biologist and pharmaceutical researchers for drug candidate screening using animal models for Parkinson's disease. The technology developed can also be applied with suitable modifications for any movement based disorders, neurological diseases and even obesity and hypertension if expressed in C.elegans.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Selvaganapathy, Ponnambalam R
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $220,250~ $0~